Literature DB >> 22858123

Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes.

Christopher R Henry1, Harry W Flynn, Darlene Miller, Richard K Forster, Eduardo C Alfonso.   

Abstract

PURPOSE: To describe the incidence, microbiology, associated factors, and clinical outcomes of patients with infectious keratitis progressing to endophthalmitis.
DESIGN: Nonrandomized, retrospective, consecutive case series. PARTICIPANTS: All patients treated for culture-proven keratitis and endophthalmitis between January 1, 1995 and December 31, 2009, at the Bascom Palmer Eye Institute.
METHODS: Ocular microbiology and medical records were reviewed on all patients with positive corneal and intraocular cultures over the period of the study. Univariate analysis was performed to obtain P values described in the study. MAIN OUTCOME MEASURES: Microbial isolates, treatment strategies, and visual acuity (VA) outcomes.
RESULTS: A total of 9934 corneal cultures were performed for suspected infectious keratitis. Only 49 eyes (0.5%) progressed to culture-proven endophthalmitis. Fungi (n = 26) were the most common responsible organism followed by gram-positive bacteria (n = 13) and gram-negative bacteria (n = 10). Topical steroid use (37/49 [76%]) was the most common associated factor identified in the current study, followed by previous surgery (30/49 [61%]), corneal perforation (17/49 [35%]), dry eye (15/49 [31%]), relative immune compromise (10/49 [20%]), organic matter trauma (9/49 [18%]), and contact lens wear (3/49 [6%]). There were 27 patients in whom a primary infectious keratitis developed into endophthalmitis, and 22 patients in whom an infectious keratitis adjacent to a previous surgical wound progressed into endophthalmitis. Patients in the primary keratitis group were more likely to be male (22/27 [81%] vs 8/22 [36%]; P = 0.001), have history of organic matter trauma (8/27 [30%] vs 1/22 [5%]); P = 0.030), and have fungal etiology (21/27 [78%] vs 5/22 [23%]; P<0.001). Patients in the surgical wound-associated group were more likely to use topical steroids (20/22 [91%] vs 17/27 [63%]; P = 0.024). A VA of ≥ 20/50 was achieved in 7 of 49 patients (14%), but was <5/200 in 34 of 49 (69%) at last follow-up. Enucleation or evisceration was performed in 15 of 49 patients (31%).
CONCLUSIONS: Progression of infectious keratitis to endophthalmitis is relatively uncommon. The current study suggests that patients at higher risk for progression to endophthalmitis include patients using topical corticosteroids, patients with fungal keratitis, patients with corneal perforation, and patients with infectious keratitis developing adjacent to a previous surgical wound. Patients with sequential keratitis and endophthalmitis have generally poor visual outcomes. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858123      PMCID: PMC3490005          DOI: 10.1016/j.ophtha.2012.06.030

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  31 in total

1.  Lecythophora mutabilis endophthalmitis after long-term corneal cyanoacrylate.

Authors:  D M Marcus; D S Hull; R M Rubin; C L Newman
Journal:  Retina       Date:  1999       Impact factor: 4.256

2.  Consecutive keratitis and Candida endophthalmitis in an immunocompromised patient with chronic lymphocytic leukaemia.

Authors:  E A Ansari; B A McVerry
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

Review 3.  Indecision about corticosteroids for bacterial keratitis: an evidence-based update.

Authors:  Kirk R Wilhelmus
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

4.  Effects of methylprednisolone and cyclosporine A on fungal growth in vitro.

Authors:  N P Bell; C L Karp; E C Alfonso; J Schiffman; D Miller
Journal:  Cornea       Date:  1999-05       Impact factor: 2.651

5.  Burkholderia cepacia keratitis with endophthalmitis.

Authors:  Kemal Örnek; Mehmet Özdemir; Ahmet Ergin
Journal:  J Med Microbiol       Date:  2009-08-06       Impact factor: 2.472

6.  Recurrent fungal keratitis and endophthalmitis.

Authors:  M X Wang; D J Shen; J C Liu; S C Pflugfelder; E C Alfonso; R K Forster
Journal:  Cornea       Date:  2000-07       Impact factor: 2.651

7.  Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.

Authors:  Rachelle A Rebong; Ricardo M Santaella; Brian E Goldhagen; Christopher P Majka; John R Perfect; William J Steinbach; Natalie A Afshari
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-21       Impact factor: 4.799

8.  Endophthalmitis associated with microbial keratitis.

Authors:  I U Scott; H W Flynn; W Feuer; S C Pflugfelder; E C Alfonso; R K Forster; D Miller
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

9.  The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses.

Authors:  E C Poggio; R J Glynn; O D Schein; J M Seddon; M J Shannon; V A Scardino; K R Kenyon
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

Review 10.  Taxonomy, biology, and clinical aspects of Fusarium species.

Authors:  P E Nelson; M C Dignani; E J Anaissie
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more
  48 in total

1.  Topical Corticosteroids in the Management of Bacterial Keratitis.

Authors:  Sonal S Tuli
Journal:  Curr Ophthalmol Rep       Date:  2013-12

Review 2.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

3.  Endoscopy-assisted vitrectomy for treatment of severe endophthalmitis with retinal detachment.

Authors:  Hui Ren; Rui Jiang; Gezhi Xu; Qing Chang; Jiahua Lv; Qinyuan Chen; Wenji Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-13       Impact factor: 3.117

4.  Periodic acid-Schiff staining demonstrates fungi in chronic anterior blepharitis.

Authors:  Z Dadaci; F Kılınç; T T Ozer; G O Sahin; N O Acir; M Borazan
Journal:  Eye (Lond)       Date:  2015-08-21       Impact factor: 3.775

5.  Comment on "Surgical management of fungal endophthalmitis resulting from fungal keratitis".

Authors:  Dubbaka Srujana; Reena Singh; Koushik Tripathy
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

6.  Persistently Vitreous Culture-Positive Exogenous Fungal Endophthalmitis.

Authors:  Ella H Leung; Ajay E Kuriyan; Harry W Flynn; Nidhi Relhan; Laura C Huang; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2016-09-16       Impact factor: 5.258

7.  Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis.

Authors:  André Ferraz Goiana Leal; Melyna Chaves Leite; Caroline Sanuzi Quirino Medeiros; Isabella Macário Ferro Cavalcanti; Almir Gonçalves Wanderley; Nereide Stela Santos Magalhães; Rejane Pereira Neves
Journal:  Mycopathologia       Date:  2014-11-28       Impact factor: 2.574

8.  Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye.

Authors:  Rajagopalaboopathi Jayasudha; Sama Kalyana Chakravarthy; Gumpili Sai Prashanthi; Savitri Sharma; Prashant Garg; Somasheila I Murthy; Sisinthy Shivaji
Journal:  J Biosci       Date:  2018-12       Impact factor: 1.826

9.  Fusarium solani Activates Dectin-1 in Experimentally Induced Keratomycosis.

Authors:  Ling-Juan Xu; Li-Xin Xie
Journal:  Curr Med Sci       Date:  2018-03-15

10.  Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes.

Authors:  Evelyn C O'Neill; Jonathan Yeoh; David C A Fabinyi; Dermot Cassidy; Rasik B Vajpayee; Penelope Allen; Paul P Connell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.